Digital Cyber resilience: Protecting tomorrow's therapies before the... As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
News Novartis hit as Lp(a) drug fails cardio outcomes trial Novartis shares have slipped after it revealed its Lp(a)-targeted drug, pelacarsen, failed to reduce cardiovascular risks in a major phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.